BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26536657)

  • 1. HRD1 suppresses the growth and metastasis of breast cancer cells by promoting IGF-1R degradation.
    Xu YM; Wang HJ; Chen F; Guo WH; Wang YY; Li HY; Tang JH; Ding Y; Shen YC; Li M; Xuan WY; Liu LH; Wang J; Wang XR; Gao ZJ; Liang XB; Su DM
    Oncotarget; 2015 Dec; 6(40):42854-67. PubMed ID: 26536657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HRD1-Mediated IGF-1R Ubiquitination Contributes to Renal Protection of Resveratrol in db/db Mice.
    Yan C; Xu W; Huang Y; Li M; Shen Y; You H; Liang X
    Mol Endocrinol; 2016 Jun; 30(6):600-13. PubMed ID: 27082896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation.
    Wang Y; Guo A; Liang X; Li M; Shi M; Li Y; Jenkins G; Lin X; Wei X; Jia Z; Feng X; Su D; Guo W
    Oncotarget; 2017 Apr; 8(14):23564-23574. PubMed ID: 28423597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Warburg effect by targeting HRD1-PFKP pathway may inhibit breast cancer progression.
    Fan Y; Wang J; Xu Y; Wang Y; Song T; Liang X; Jin F; Su D
    Cell Commun Signal; 2021 Feb; 19(1):18. PubMed ID: 33588886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E3 Ubiquitin Ligase HRD1 Promotes Lung Tumorigenesis by Promoting Sirtuin 2 Ubiquitination and Degradation.
    Liu L; Yu L; Zeng C; Long H; Duan G; Yin G; Dai X; Lin Z
    Mol Cell Biol; 2020 Mar; 40(7):. PubMed ID: 31932479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
    Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
    Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial-mesenchymal transition by upregulating slug expression.
    Song Y; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
    Exp Mol Pathol; 2015 Dec; 99(3):617-27. PubMed ID: 26505174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hrd1 induces cardiomyocyte apoptosis via regulating the degradation of IGF-1R by sema3a.
    Liu X; Zhou N; Sui X; Pei Y; Liang Z; Hao S
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3615-3622. PubMed ID: 30248386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Hrd1 in ultraviolet (UV) radiation induced photoaging.
    Jin Y; Cheng X; Huang X; Ding F; Lee SR; Wang F; Lu X; Su D; Chen B
    Aging (Albany NY); 2020 Nov; 12(21):21273-21289. PubMed ID: 33168784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
    Latorre E; Carelli S; Raimondi I; D'Agostino V; Castiglioni I; Zucal C; Moro G; Luciani A; Ghilardi G; Monti E; Inga A; Di Giulio AM; Gorio A; Provenzani A
    Cancer Res; 2016 May; 76(9):2626-36. PubMed ID: 27197265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway.
    Li XX; Huang LY; Peng JJ; Liang L; Shi DB; Zheng HT; Cai SJ
    Int J Oncol; 2014 Aug; 45(2):611-8. PubMed ID: 24818842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
    Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW
    Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia.
    Ren T; Zhang W; Liu X; Zhao H; Zhang J; Zhang J; Li X; Zhang Y; Bu X; Shi M; Yao L; Su J
    J Pathol; 2014 Dec; 234(4):526-37. PubMed ID: 25130389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
    Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
    Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor (PEDF) inhibits breast cancer metastasis by down-regulating fibronectin.
    Hong H; Zhou T; Fang S; Jia M; Xu Z; Dai Z; Li C; Li S; Li L; Zhang T; Qi W; Bardeesi AS; Yang Z; Cai W; Yang X; Gao G
    Breast Cancer Res Treat; 2014 Nov; 148(1):61-72. PubMed ID: 25284724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of HRD1 promotes cell migration and invasion in colon cancer.
    Tan X; He X; Fan Z
    Mol Cell Biochem; 2019 Apr; 454(1-2):1-9. PubMed ID: 30306455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
    Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
    J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
    An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
    Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells.
    Rao W; Li H; Song F; Zhang R; Yin Q; Wang Y; Xi Y; Ge H
    Carcinogenesis; 2014 Jul; 35(7):1573-81. PubMed ID: 24667688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-340 suppresses cell migration and invasion by targeting MYO10 in breast cancer.
    Chen CP; Sun ZL; Lu X; Wu WX; Guo WL; Lu JJ; Han C; Huang JQ; Fang Y
    Oncol Rep; 2016 Feb; 35(2):709-16. PubMed ID: 26573744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.